Similar Search Results

Leading pharmaceutical innovation : how to win the life science race

Gassmann, Oliver; Schuhmacher, Alexander; Zedtwitz, … - 2018 - Third edition

of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for … cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R … expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture …

Persistent link: https://www.econbiz.de/10012397599

Außenhandel und Technologie : Endogene Sunk Costs im allgemeinen Gleichgewicht

Eckel, Carsten (contributor) - 2008

Endogene Sunk Costs und die Kostenstruktur -- Endogene Sunk Costs in einem „Love of Variety“ Modell -- Endogene Sunk Costs in einem „Ideal Variety“ Modell -- Anwendungen der Modelle mit endogenen Sunk Costs -- Schlussbemerkungen.

Persistent link: https://www.econbiz.de/10013516828

Risk-sharing in the Pharmaceutical Industry : The Case of Out-licensing

Reepmeyer, Gerrit (contributor) - 2006

Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...

Persistent link: https://www.econbiz.de/10013520588